Alkermes ALKS
NASDAQ ALKS
$45.31 -0.18 (-0.40%)
As of: Sep 9, 2026 · 2:06 PM EDT

Alkermes (ALKS) Raw Materials (2011 - 2026)

Alkermes' (ALKS) quarterly Raw Materials came in at $70.1 million in Q2 2026, up 2.46% year-over-year from $68.4 million in Q2 2025, and down 1.21% quarter-over-quarter from $71.0 million in Q1 2026.

Analysis

Alkermes (ALKS) Raw Materials (2011 - 2026) Analysis & Trends

Alkermes (ALKS) has reported Raw Materials for 16 consecutive years, with $70.1 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Raw Materials rose 2.46% year-over-year to $70.1 million in Q2 2026; TTM through Jun 2026 was $70.1 million, a 2.46% increase from a year earlier, with the FY2025 full-year figure at $68.4 million, down 5.2% from the prior year.
  • Raw Materials was $70.1 million for Q2 2026 at Alkermes, down from $71.0 million in the prior quarter.
  • Over five years, Raw Materials peaked at $78.3 million in Q3 2024 and troughed at $51.4 million in Q1 2022.
  • A 5-year average of $66.5 million and a median of $68.4 million in 2025 frame the typical range for Raw Materials.
  • Across the five-year window, Raw Materials surged 31.54% in 2024 and slipped 15.47% in 2025, its largest moves.
  • Over 5 years, Raw Materials stood at $61.1 million in 2022, then grew by 16.95% to $71.4 million in 2023, then climbed by 1.01% to $72.1 million in 2024, then declined by 5.2% to $68.4 million in 2025, then rose by 2.52% to $70.1 million in 2026.
  • The last three Raw Materials figures came in at $70.1 million (Q2 2026), $71.0 million (Q1 2026), and $68.4 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 646.24 Bn 625.48 Bn 17.26 Bn
2 AbbVie 441.52 Bn 434.96 Bn 12.70 Bn
3 Merck 365.75 Bn 358.60 Bn 12.21 Bn
4 Novartis Ag 266.61 Bn 258.92 Bn 11.24 Bn
5 Pfizer 159.09 Bn 147.39 Bn 10.94 Bn
6 Sanofi 52.43 Bn 45.05 Bn 10.79 Bn
7 Revolution Medicines 44.04 Bn 44.04 Bn -
8 Incyte 25.32 Bn 20.79 Bn 1.57 Bn
9 United Therapeutics 21.43 Bn 18.77 Bn 683.80 Mn
10 Alkermes 7.56 Bn 6.90 Bn 397.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 70.11 Mn
Mar 31, 2026 70.97 Mn
Dec 31, 2025 68.39 Mn
Sep 30, 2025 66.23 Mn
Jun 30, 2025 68.42 Mn
Mar 31, 2025 69.69 Mn
Dec 31, 2024 72.14 Mn
Sep 30, 2024 78.34 Mn
Jun 30, 2024 76.12 Mn
Mar 31, 2024 76.56 Mn
Dec 31, 2023 71.42 Mn
Sep 30, 2023 68.32 Mn
Jun 30, 2023 57.87 Mn
Mar 31, 2023 59.05 Mn
Dec 31, 2022 61.06 Mn
Sep 30, 2022 57.89 Mn
Jun 30, 2022 52.87 Mn
Mar 31, 2022 51.43 Mn
Dec 31, 2021 56.13 Mn
Sep 30, 2021 46.25 Mn